Stella Vincent

1.2k total citations
35 papers, 712 citations indexed

About

Stella Vincent is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Stella Vincent has authored 35 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Stella Vincent's work include Peroxisome Proliferator-Activated Receptors (10 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Stella Vincent is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Stella Vincent collaborates with scholars based in United States, France and Japan. Stella Vincent's co-authors include Ronald B. Franklin, Shiyao Xu, Bindhu V. Karanam, James R. Reed, Bing Zhu, George A. Doss, Charles S. Elmore, David Q. Liu, Christopher J. Kochansky and Kenneth C. Lasseter and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Medicinal Chemistry and Chemical Research in Toxicology.

In The Last Decade

Stella Vincent

35 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stella Vincent United States	16	285	205	182	145	100	35	712
George Tonn United States	17	332 1.2×	114 0.6×	242 1.3×	256 1.8×	178 1.8×	31	939
Mary T. Obermeier United States	12	213 0.7×	233 1.1×	96 0.5×	95 0.7×	106 1.1×	19	606
Bindhu V. Karanam United States	14	249 0.9×	70 0.3×	92 0.5×	95 0.7×	66 0.7×	23	583
Hequn Yin United States	11	194 0.7×	114 0.6×	161 0.9×	188 1.3×	35 0.3×	20	508
Masamitsu Maekawa Japan	20	461 1.6×	55 0.3×	386 2.1×	175 1.2×	97 1.0×	101	1.2k
Kazutomi Kusano Japan	20	310 1.1×	57 0.3×	241 1.3×	269 1.9×	44 0.4×	46	902
Matthew A. Cerny United States	14	170 0.6×	88 0.4×	218 1.2×	349 2.4×	91 0.9×	25	655
Hans Helleberg Denmark	8	292 1.0×	227 1.1×	53 0.3×	51 0.4×	32 0.3×	18	783
David L. Bourdet United States	14	182 0.6×	58 0.3×	317 1.7×	194 1.3×	59 0.6×	37	821
K. J. Kripalani United States	14	227 0.8×	90 0.4×	89 0.5×	150 1.0×	54 0.5×	25	700

Countries citing papers authored by Stella Vincent

Since Specialization

Citations

This map shows the geographic impact of Stella Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Vincent more than expected).

Fields of papers citing papers by Stella Vincent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Vincent. The network helps show where Stella Vincent may publish in the future.

Co-authorship network of co-authors of Stella Vincent

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Vincent. A scholar is included among the top collaborators of Stella Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Vincent. Stella Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Wensheng, Yongqi Deng, David L. Sloman, et al.. (2021). Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold. Bioorganic & Medicinal Chemistry Letters. 49. 128314–128314. 6 indexed citations

Keohane, Carol, et al.. (2007). Effect of enalapril on thein vitroandin vivopeptidyl cleavage of a potent VLA-4 antagonist. Xenobiotica. 37(5). 487–502. 8 indexed citations

Wang, Haiping, Richard W. Edom, Sanjeev Kumar, Stella Vincent, & Zhongzhou Shen. (2007). Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry. Journal of Chromatography B. 854(1-2). 26–34. 4 indexed citations

Vincent, Stella, James R. Reed, Arthur Bergman, et al.. (2007). Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans. Drug Metabolism and Disposition. 35(4). 533–538. 127 indexed citations

Zhu, Bing, et al.. (2007). Characterization of 1′-Hydroxymidazolam Glucuronidation in Human Liver Microsomes. Drug Metabolism and Disposition. 36(2). 331–338. 47 indexed citations

Kochansky, Christopher J., Michael A. Wallace, Dennis Dean, et al.. (2006). Absorption, Metabolism, and Excretion of [14C]MK-0767 (2-Methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in Humans. Drug Metabolism and Disposition. 34(9). 1457–1461. 5 indexed citations

Anari, M. Reza, Jason S. Ngui, Richard A. Tschirret-Guth, et al.. (2006). SPECIES DIFFERENCES IN METABOLISM AND PHARMACOKINETICS OF A SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST IN RATS AND DOGS: FORMATION OF A UNIQUE GLUTATHIONE ADDUCT IN THE RAT. Drug Metabolism and Disposition. 34(8). 1367–1375. 5 indexed citations

Shen, Zhongzhou, Ray Bakhtiar, Katsuya Awano, et al.. (2005). Enantiomer ratio of MK‐0767 in humans and nonclinical species. Rapid Communications in Mass Spectrometry. 19(9). 1125–1129. 9 indexed citations

Doss, George A., et al.. (2004). IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS. Drug Metabolism and Disposition. 32(10). 1154–1161. 7 indexed citations

10.

Karanam, Bindhu V., et al.. (2004). SPECIES DIFFERENTIAL STEREOSELECTIVE OXIDATION OF A METHYLSULFIDE METABOLITE OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)PHENYL]METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DUAL AGONIST. Drug Metabolism and Disposition. 32(10). 1061–1068. 11 indexed citations

11.

Kim, Misook, Sui Wang, Zhongzhou Shen, et al.. (2004). DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS. Drug Metabolism and Disposition. 32(9). 909–914. 28 indexed citations

12.

Liu, David Q., et al.. (2004). IN VITRO METABOLISM OF MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL)-PHENYL] METHYL]BENZAMIDE], A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. II. IDENTIFICATION OF METABOLITES BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. Drug Metabolism and Disposition. 32(9). 1023–1031. 17 indexed citations

13.

Strauss, John R., et al.. (2003). Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR⁻rats. Xenobiotica. 33(10). 1027–1044. 16 indexed citations

14.

Wang, Sui, et al.. (2003). INDUCTION OF HEPATIC PHASE II DRUG-METABOLIZING ENZYMES BY 1,7-PHENANTHROLINE IN RATS IS ACCOMPANIED BY INDUCTION OF MRP3. Drug Metabolism and Disposition. 31(6). 773–775. 17 indexed citations

15.

Shen, Z., James R. Reed, D. F. Hora, et al.. (2003). Identification of novel metabolites of pioglitazone in rat and dog. Xenobiotica. 33(5). 499–509. 30 indexed citations

16.

Young, Jonathan R., Thomas F. Walsh, Matthew J. Wyvratt, et al.. (2002). 2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain. Bioorganic & Medicinal Chemistry Letters. 12(5). 827–832. 32 indexed citations

17.

Bugianesi, Robert L., Mitree M. Ponpipom, Yi Yang, et al.. (2002). Modification of the pyridine moiety of non-peptidyl indole GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(22). 3329–3332. 12 indexed citations

18.

Xia, Yuanqing, Cornelis E. C. A. Hop, David Q. Liu, Stella Vincent, & Shuet‐Hing Lee Chiu. (2001). Parallel extraction columns and parallel analytical columns coupled with liquid chromatography/tandem mass spectrometry for on‐line simultaneous quantification of a drug candidate and its six metabolites in dog plasma. Rapid Communications in Mass Spectrometry. 15(22). 2135–2144. 12 indexed citations

19.

Ashton, Wallace T., G. R. KIECZYKOWSKI, Joel B. Yudkovitz, et al.. (2001). Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity. Bioorganic & Medicinal Chemistry Letters. 11(19). 2597–2602. 42 indexed citations

20.

Zagrobelny, JoAnn, B.K. Matuszewski, W. F. Kline, & Stella Vincent. (1998). Separation of the four stereoisomers of a potent inhibitor (L-694,458) of human leukocyte elastase and its determination in human plasma using achiral/chiral chromatography with column switching. Journal of Pharmaceutical and Biomedical Analysis. 17(6-7). 1057–1064. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact